GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Interest Expense

Sun Pharma Advanced Research Co (NSE:SPARC) Interest Expense : ₹-23.7 Mil (TTM As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sun Pharma Advanced Research Co's interest expense for the three months ended in Sep. 2024 was ₹ -11.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-23.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Sun Pharma Advanced Research Co's Operating Income for the three months ended in Sep. 2024 was ₹ -1,060.7 Mil. Sun Pharma Advanced Research Co's Interest Expense for the three months ended in Sep. 2024 was ₹ -11.4 Mil. Sun Pharma Advanced Research Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sun Pharma Advanced Research Co Interest Expense Historical Data

The historical data trend for Sun Pharma Advanced Research Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co Interest Expense Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.75 -106.50 -133.29 -76.35 -11.95

Sun Pharma Advanced Research Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.60 -2.60 -4.15 -5.60 -11.40

Sun Pharma Advanced Research Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-23.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharma Advanced Research Co  (NSE:SPARC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sun Pharma Advanced Research Co's Interest Expense for the three months ended in Sep. 2024 was ₹-11.4 Mil. Its Operating Income for the three months ended in Sep. 2024 was ₹-1,060.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was ₹0.0 Mil.

Sun Pharma Advanced Research Co's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Sun Pharma Advanced Research Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Sun Pharma Advanced Research Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Interest Expense
Comparable Companies
BOM:543322 BOM:524742 BOM:532482 BOM:500126 BOM:530019 BOM:531599 BOM:524558 NSE:STAR BOM:524348 BOM:543748 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
532872:India
Address
Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Website
https://www.sparc.life
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines